Drug

CDSCO approves Zaynich antibiotic ahead of FDA approval

Zaynich is a broad-spectrum antibiotic indicated for bacterial infections including odontogenic abscesses; dosing follows standard adult regimens (e.g., 500 mg twice daily) pending local guidelines; approved by CDSCO on 27 May 2026; available in India; offers a new option for managing resistant oral pathogens.

Source: Biotecnika

Read more dental news on DentalSync

18 Nov 2026 · DentalSync AI — global BDS career platform